Search

everythinglearnresearchcommunity

for

Search:↓

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

TAK-279 effectively reduces psoriasis symptoms and is safe.

The ointment effectively treats neurodermatitis and chronic eczema without causing skin irritation.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A new compound shows promise as a topical treatment for hair loss.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.